Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2009 1
2011 1
2012 3
2013 1
2015 2
2016 2
2017 2
2018 1
2019 2
2020 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Fallopian Tube Mucinous Adenocarcinoma"
Page 1
Treatment of ovarian cancer in young women.
Gershenson DM. Gershenson DM. Clin Obstet Gynecol. 2012 Mar;55(1):65-74. doi: 10.1097/GRF.0b013e318248045b. Clin Obstet Gynecol. 2012. PMID: 22343230 Review.
However, invasive epithelial ovarian cancers may also occur in young women, particularly the subtypes of low-grade serous carcinoma and mucinous carcinoma. This article details the diagnosis and optimal treatment of ovarian cancers subtypes in young women....
However, invasive epithelial ovarian cancers may also occur in young women, particularly the subtypes of low-grade serous carcinoma and m
Primary Mucinous Carcinoma of the Fallopian Tube: Case Report and Review of Literature.
Wheal A, Jenkins R, Mikami Y, Das N, Hirschowitz L. Wheal A, et al. Int J Gynecol Pathol. 2017 Jul;36(4):393-399. doi: 10.1097/PGP.0000000000000330. Int J Gynecol Pathol. 2017. PMID: 27662036 Review.
Primary mucinous carcinoma of the fallopian tube is extremely rare. We report the detailed characterization of a mucinous carcinoma arising in the fimbrial end of the fallopian tube in a 74-yr-old woman. ...There was no mucinous me …
Primary mucinous carcinoma of the fallopian tube is extremely rare. We report the detailed characterization of a muc
Mucinous appendiceal adenocarcinoma invading the bladder: not always an easy diagnosis. A case report.
Eugenia L, Giovanni A, Andrea M, Maria Rosaria R, Gianni V, Mara B, Gherardo M, Daniele L, Lorenzo A, Andrea M, Paolo P. Eugenia L, et al. Anticancer Drugs. 2023 Sep 1;34(8):967-969. doi: 10.1097/CAD.0000000000001499. Epub 2023 Jan 24. Anticancer Drugs. 2023. PMID: 36688906
Cystoscopic examination showed a large lesion on the right side of posterior bladder wall, with multiple ulcerated areas and microscopical examination of the specimen revealed a mucinous adenocarcinoma infiltrating urinary bladder. Contrast-enhanced computed tomogra …
Cystoscopic examination showed a large lesion on the right side of posterior bladder wall, with multiple ulcerated areas and microscopical e …
Borderline mucinous tumor arising in a paratubal cyst: a case report.
Im HS, Kim JO, Lee SJ, Lee YS, Park EK. Im HS, et al. Eur J Gynaecol Oncol. 2011;32(2):206-7. Eur J Gynaecol Oncol. 2011. PMID: 21614917
We describe the first case of a paratubal borderline mucinous tumor (PBMT). CASE REPORT: A 20-year-old woman was referred with a complex right adnexal mass on pelvic sonogram. ...Frozen section analysis was reported as a borderline mucinous tumor of low malignant po …
We describe the first case of a paratubal borderline mucinous tumor (PBMT). CASE REPORT: A 20-year-old woman was referred with a comp …
When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviews.
Zhou Y, Wang X, Li Y, Zhang W, Xu X, Pang Y, Liu P. Zhou Y, et al. BMC Womens Health. 2024 Jun 28;24(1):375. doi: 10.1186/s12905-024-03184-y. BMC Womens Health. 2024. PMID: 38937781 Free PMC article. Review.
BACKGROUND: Peutz-Jeghers syndrome (PJS) is characterized by the presence of hamartomatous polyps in the gastrointestinal tract and mucocutaneous pigmentation on the lips, oral mucosa, nose, fingers, and toes. Synchronous mucinous metaplasia and neoplasia of the female gen …
BACKGROUND: Peutz-Jeghers syndrome (PJS) is characterized by the presence of hamartomatous polyps in the gastrointestinal tract and mucocuta …
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS. Safra T, et al. Int J Gynecol Cancer. 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944. Int J Gynecol Cancer. 2013. PMID: 23435437 Clinical Trial.
OBJECTIVES: The purpose of this study was to assess the clinical activity and toxicity of weekly topotecan in a large cohort of epithelial ovarian (EOC), primary peritoneal (PPC), and tubal cancer patients. METHODS: Records of patients with recurrent EOC, PPC, and tubal ca …
OBJECTIVES: The purpose of this study was to assess the clinical activity and toxicity of weekly topotecan in a large cohort of epithelial o …
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W. Xu B, et al. Hum Pathol. 2015 Jun;46(6):858-67. doi: 10.1016/j.humpath.2015.02.012. Epub 2015 Mar 5. Hum Pathol. 2015. PMID: 25841306
Epithelial ovarian cancer is composed of a diverse group of tumors that can be derived from the fallopian tube, endometrium, or ovary. In this study, we explored the expression levels of LATS family members in ovarian tumors using normal ovaries, fallopian
Epithelial ovarian cancer is composed of a diverse group of tumors that can be derived from the fallopian tube, endometrium, o …
Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia.
Mikami Y, Kiyokawa T, Sasajima Y, Teramoto N, Wakasa T, Wakasa K, Hata S. Mikami Y, et al. Histopathology. 2009 Jan;54(2):184-91. doi: 10.1111/j.1365-2559.2008.03202.x. Histopathology. 2009. PMID: 19207943
All six patients had mucinous metaplasia of endometrium, which showed features of lobular endocervical glandular hyperplasia (LEGH)/pyloric gland metaplasia (PGM) in five and was associated with mucinous adenocarcinoma in three. Five patients had mucinous
All six patients had mucinous metaplasia of endometrium, which showed features of lobular endocervical glandular hyperplasia (LEGH)/p …
Synchronous Cervical Minimal Deviation Adenocarcinoma, Gastric Type Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia Along with STIL in Peutz-Jeghers Syndrome: Eliciting Oncogenesis Pathways.
Neyaz A, Husain N, Deodhar M, Khurana R, Shukla S, Arora A. Neyaz A, et al. Turk Patoloji Derg. 2019;35(3):247-253. doi: 10.5146/tjpath.2017.01406. Turk Patoloji Derg. 2019. PMID: 28832082 Free article. English.
We describe an unusual case of a Peutz-Jeghers syndrome associated with a composite synchronous cervical neoplasia comprising precursor "lobular endocervical glandular hyperplasia (LEGH)", "minimal deviation adenocarcinoma (MDA)" and "gastric-type adenocarcinoma (GT …
We describe an unusual case of a Peutz-Jeghers syndrome associated with a composite synchronous cervical neoplasia comprising precursor "lob …
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
Rocconi RP, Sullivan P, Long B, Blaize M, Brown J, Arbuckle J, Bevis K, Estes JM, Reed E, Finan MA. Rocconi RP, et al. Int J Gynecol Cancer. 2012 Jun;22(5):786-91. doi: 10.1097/IGC.0b013e31825104f4. Int J Gynecol Cancer. 2012. PMID: 22552832

Compared with the ESA-NO group, ESA-YES patients were significantly more likely to experience recurrence (56% vs 80%, P < 0.001) and death (46% vs 59%, P = 0.002). Kaplan-Meier curves demonstrated a significant reduction in progression-free survival for ESA-YES patients

Compared with the ESA-NO group, ESA-YES patients were significantly more likely to experience recurrence (56% vs 80%, P < 0.001) a

18 results